Vaccine & biotherapeutics pipeline

Vaccines

Biotherapeutic

Segment Candidate Discovery Preclinical IND/CTA Ready Clinical Rights Funding
Zika Read More
FluVid
Influenza Read More
Covid-19-S Read More
Norovirus
Nipah
GI therapeutics Read More
Oncology Read More
Vaccines
Biotherapeutics
Vaccines
Biotherapeutics

Follow us

Keep up to date with our news and find out more about investment opportunities with iosBio.

The team of doctors and scientists at iosBio believe that the next great leap forward in immunization will be oral delivery


Enabling the fastest and most cost-effective deployment of vaccines the world has ever seen. This is not just a huge leap forward from a humanitarian perspective, oral vaccine technology also represents a significant commercial opportunity.

    We will not, in any circumstances share your personal information with other individuals or organizations without your permission.